Literature DB >> 11981800

Techniques in dosing for thrombolysis of occluded central venous catheters.

W D Haire1.   

Abstract

Dosing of thrombolytic agents for restoration of flow to thrombotically occluded central venous catheters has been empiric. The lowest effective dose of any agent is not known. Given that none of the dosing regimens in current use has ever been found to be toxic, this is probably not a major clinical problem as long as the regimen is highly effective. Thrombolytic regimens differ in the type of drug, dose of drug, method of administration (injection versus prolonged infusion), and duration of administration. All of these variables are important in determining the efficacy, and possibly the toxicity, of a regimen. Active research is being conducted to determine the most effective ways of using the expanding number of thrombolytic medications that are now, or soon may be, on the market. Copyright 2001 by W.B. Saunders Company

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11981800     DOI: 10.1016/s1089-2516(01)90008-3

Source DB:  PubMed          Journal:  Tech Vasc Interv Radiol        ISSN: 1557-9808


  5 in total

1.  A dose-finding clinical trial of staphylokinase SY162 in patients with long-term venous access catheter thrombotic occlusion.

Authors:  Peter Verhamme; Godelieve Goossens; Geert Maleux; Désiré Collen; Marguerite Stas
Journal:  J Thromb Thrombolysis       Date:  2007-02-03       Impact factor: 2.300

2.  Urokinase for restoring patency of malfunctioning or blocked central venous catheters in children with hemato-oncological diseases.

Authors:  Angelo Claudio Molinari; Riccardo Haupt; Paola Saracco; Maria Di Marco; Elio Castagnola; Giuseppe Fratino
Journal:  Support Care Cancer       Date:  2004-09-09       Impact factor: 3.603

3.  Interventions to obstructive long-term central venous catheter in cancer patients: a meta-analysis.

Authors:  Ana Cristina Carvalho da Costa; Jéssica Marques Ribeiro; Christiane Inocêncio Vasques; Graziela De Luca Canto; André Luís Porporatti; Paula Elaine Diniz Dos Reis
Journal:  Support Care Cancer       Date:  2018-10-29       Impact factor: 3.603

4.  Catheter-related septic thrombophlebitis of the great central veins successfully treated with low-dose streptokinase thrombolysis and antimicrobials.

Authors:  Patricia Volkow; Patricia Cornejo-Juárez; Rogelio Pérez-Padilla; Ana Berta Arizpe-Bravo; Jorge García-Méndez; Enrique Baltazares-Lipp
Journal:  Thromb J       Date:  2005-08-22

5.  Prevention of catheter lumen occlusion with rT-PA versus heparin (Pre-CLOT): study protocol of a randomized trial [ISRCTN35253449].

Authors:  Brenda R Hemmelgarn; Louise Moist; Rachel M Pilkey; Charmaine Lok; Marc Dorval; Paul Y W Tam; Murray J Berall; Martine LeBlanc; Edwin B Toffelmire; Braden J Manns; Nairne Scott-Douglas
Journal:  BMC Nephrol       Date:  2006-04-11       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.